scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1600-0897.1986.TB00001.X |
P8608 | Fatcat ID | release_5lb7i7m3abawbhfexjr74e7smi |
P698 | PubMed publication ID | 2938488 |
P2093 | author name string | K Kanazawa | |
S Takeuchi | |||
K Takakuwa | |||
P2860 | cites work | Maternal isoimmunisation resulting in combined immunodeficiency and fatal graft-versus-host disease in an infant | Q33475804 |
Antigens of human trophoblast. Effects of heterologous anti-trophoblast sera on lymphocyte responses in vitro | Q36341349 | ||
Anti-idiotypic antibodies to anti-HLA receptors induced by pregnancy | Q37603240 | ||
Maternal cell-mediated immunity to the fetus in human pregnancy | Q39613809 | ||
Immunology of Spontaneous Abortion and Hydatidiform Mole* | Q41641585 | ||
Maternal-fetal relation. II. Further characterization of an immunologic blocking factor that develops during pregnancy | Q46308759 | ||
P433 | issue | 1 | |
P921 | main subject | antibody | Q79460 |
P304 | page(s) | 1-9 | |
P577 | publication date | 1986-01-01 | |
P1433 | published in | American journal of reproductive immunology and microbiology : AJRIM | Q26853974 |
P1476 | title | Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy | |
P478 | volume | 10 |
Q58377327 | Immunotherapy for Recurrent Spontaneous Abortions in a Chinese Population |
Q68052576 | Immunotherapy with paternal lymphocytes preceding in vitro fertilization-embryo transfer for patients with repeated failure of embryo transfer |
Q73175937 | Increased frequency of HLA-DR4 allele in women with unexplained recurrent spontaneous abortions, detected by the method of PCR-SSP |
Q67706729 | Influence of immunotherapy on the cellular immunity of unexplained recurrent aborters |
Q52423603 | Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results. |
Q40673466 | Intravenous immune globulin in recurrent abortion. |
Q37790359 | Is production of blocking antibodies in successful human pregnancy an epiphenomenon? |
Q72814595 | Limiting dilution analysis of the allo-MHC anti-paternal cytotoxic T cell response. II: Recurrent spontaneous abortion and the effect of immunotherapy |
Q45026671 | MLR-blocking antibodies are directed against alloantigens expressed on syncytiotrophoblasts |
Q38763945 | Materno-trophoblastic immunological balance |
Q42605333 | Predictors for live birth after unexplained spontaneous abortions: correlations between immunologic test results, obstetric histories, and outcome of next pregnancy without treatment |
Q42619179 | Probabilistic assessment of the HLA sharing of recurrent spontaneous abortion couples in the Japanese population |
Q68213315 | Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions |
Q73297935 | Results of immunotherapy for patients with unexplained secondary recurrent abortions |
Q42017270 | Role of children's sex in mixed mother-child lymphocyte culture reactivity |
Q68440888 | Selection of patients with habitual abortion for paternal leucocyte immunization |
Q44525432 | Serum levels of anticardiolipin antibodies are pathologically increased after active immunization of patients with recurrent spontaneous abortion |
Q80537299 | Sex differences of abortuses and neonates in women with allo-immune recurrent abortions |
Q58377330 | Sharing of human leukocyte antigens in primary and secondary recurrent spontaneous abortions |
Q42601647 | Significant compatibility does not exist at the HLA-DQB gene locus in couples with unexplained recurrent abortions |
Q73778654 | Suppressed cell-mediated immunity and monocyte and natural killer cell activity following allogeneic immunization of women with spontaneous recurrent abortion |
Q68309272 | Systematization of clinical management for recurrent aborters by combined immunological testing |
Q67576003 | The role of blocking factors and antipaternal lymphocytotoxic antibodies in the success of pregnancy in patients with recurrent spontaneous abortion |
Q61839323 | Trophoblast membrane infusion for unexplained recurrent miscarriage |